2010-23824. Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Hazard Analysis and Critical Control Point Procedures for the Safe and Sanitary Processing and Importing of Juice
-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
DATES:
Fax written comments on the collection of information by October 25, 2010.
ADDRESSES:
To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202-395-7285, or emailed to oira_submission@omb.eop.gov . All comments should be identified with the OMB control number 0910-0466. Also include the FDA docket number found in brackets in the heading of this document.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Denver Presley, Jr., Office of Information Management (HFA-710), Food and Drug Administration, 1350 Piccard Dr., Rockville, MD 20850, 301-796-3793.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance.
Hazard Analysis and Critical Control Point (HACCP) Procedures for the Safe and Sanitary Processing and Importing of Juice—(OMB Control Number 0910-0466)—Extension
FDA's regulations in part 120 (21 CFR part 120) mandate the application of HACCP procedures to fruit and vegetable juice processing. HACCP is a preventative system of hazard control that can be used by all food processors to ensure the safety of their products to consumers. A HACCP system of preventive controls is the most effective and efficient way to ensure that these food products are safe. FDA's mandate to ensure the safety of the Nation's food supply is derived principally from the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 321, et seq. ). Under the FD&C Act, FDA has authority to ensure that all foods in interstate commerce, or that have been shipped in interstate commerce, are not contaminated or otherwise adulterated, are produced and held under sanitary conditions, and are not misbranded or deceptively packaged; under section 701 (21 U.S.C. 371), the FD&C Act authorizes the Agency to issue regulations for its efficient enforcement. The Agency also has authority under section 361 of the Public Health Service Act (42 U.S.C. 264) to issue and enforce regulations to prevent the introduction, transmission, or spread of Start Printed Page 57963 communicable diseases from one State to another State. Information development and recordkeeping are essential parts of any HACCP system. The information collection requirements are narrowly tailored to focus on the development of appropriate controls and document those aspects of processing that are critical to food safety. Through these regulations, FDA is implementing its authority under section 402(a)(4) of the FD&C Act (21 U.S.C. 342(a)(4)).
In the Federal Register of July 14, 2010 (75 FR 40839), FDA published a 60-day notice requesting public comment on the proposed collection of information. No comments were received.
FDA estimates the burden of this collection of information as follows:
Table 1.—Estimated Annual Reporting Burden1
21 CFR Section No of Recordkeepers Annual Frequency per Recordkeeping Total Annual Records Hours Per Record Total Hours 120.6(c) and 120.12(a)(1) and (b) 1,875 365 684,375 0.1 68,437.5 120.7; 120.10(a); and 120.12(a)(2), (b), and (c) 2,300 1.1 2,530 20 50,600 120.8(b)(7) and 120.12(a)(4)(i) and (b) 1,450 14,600 21,170,000 0.01 211,700 120.10(c) and 120.12(a)(4)(ii) and (b) 1,840 12 22,080 0.1 2,208 120.11(a)(1)(iv) and (a)(2) and 120.12(a)(5) 1,840 52 95,680 0.1 9,568 120.11(b) and 120.12(a)(5) and (b) 1,840 1 1,840 4 7,360 120.11(c) and 120.12(a)(5) and (b) 1,840 1 1,840 4 7,360 120.14(a)(2), (c), and (d) 308 1 308 4 1,232 Total 358,466 1 There are no capital costs or operating and maintenance costs associated with this collection of information. Table 1 of this document provides a breakdown of the total estimated annual recordkeeping burden. FDA bases this hour burden estimate on its experience with the application of HACCP principles in food processing.
The burden estimates in table 1 of this document are based on an estimate of the total number of juice manufacturing plants (i.e., 2,300) affected by the regulations. Included in this total are 850 plants currently identified in FDA's official establishment inventory plus 1,220 very small apple juice manufacturers and 230 very small orange juice manufacturers. The total burden hours are derived by estimating the number of plants affected by each portion of the final rule and multiplying the corresponding number by the number of records required annually and the hours needed to complete the record. These numbers were obtained from the Agency's final regulatory impact analysis prepared for these regulations.
Moreover, these estimates assume that every processor will prepare sanitary standard operating procedures and a HACCP plan and maintain the associated monitoring records and that every importer will require product safety specifications. In fact, there are likely to be some small number of juice processors that, based upon their hazard analysis, determine that they are not required to have a HACCP plan under the regulations.
Start SignatureDated: September 20, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-23824 Filed 9-22-10; 8:45 am]
BILLING CODE 4160-01-S
Document Information
- Comments Received:
- 0 Comments
- Published:
- 09/23/2010
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice.
- Document Number:
- 2010-23824
- Dates:
- Fax written comments on the collection of information by October 25, 2010.
- Pages:
- 57962-57963 (2 pages)
- Docket Numbers:
- Docket No. FDA-2010-N-0357
- PDF File:
- 2010-23824.pdf